ECSP045218A - "novedosos inhibidores de la gamma secretasa" - Google Patents

"novedosos inhibidores de la gamma secretasa"

Info

Publication number
ECSP045218A
ECSP045218A EC2004005218A ECSP045218A ECSP045218A EC SP045218 A ECSP045218 A EC SP045218A EC 2004005218 A EC2004005218 A EC 2004005218A EC SP045218 A ECSP045218 A EC SP045218A EC SP045218 A ECSP045218 A EC SP045218A
Authority
EC
Ecuador
Prior art keywords
alkyl
secretasa
gamma
new inhibitors
group
Prior art date
Application number
EC2004005218A
Other languages
English (en)
Inventor
Dmitri A Pissarnitski
Hubert B Josien
Elizabeth M Smith
John W Clader
Theodros Asberom
Tao Guo
Douglas W Hobbs
Original Assignee
Schering Corp
Pharmacopeia Drug Discovery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, Pharmacopeia Drug Discovery filed Critical Schering Corp
Publication of ECSP045218A publication Critical patent/ECSP045218A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invención revela novedosos inhibidores de la gamma secretasa, de la Fórmula: en la cual: R1 es un grupo arilo sustituido ó heteroarilo sustituido; R2 es es un grupo R1 , alquilo, -X(CO)Y, ó alquileno-X(CO)Y, siendo X e Y como anteriormente definidos: cada uno de los R3 y cada uno de los R3A es independientemente entre sí Hó alquilo; R11 es alquilo, heteroarilo, alquilo, cicloalquilo, arilalquilo, arilcicloalquilo, heteroarilalquilo, heteroarilcicloalquilo, arilheterocicloalquilo, ó alcoxialquilo.También se revela un método para tratar la Enfermedad de Alzheirmer mediante uno ó más compuestos de la invención.
EC2004005218A 2002-02-06 2004-08-03 "novedosos inhibidores de la gamma secretasa" ECSP045218A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35561802P 2002-02-06 2002-02-06

Publications (1)

Publication Number Publication Date
ECSP045218A true ECSP045218A (es) 2004-09-28

Family

ID=27734543

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005218A ECSP045218A (es) 2002-02-06 2004-08-03 "novedosos inhibidores de la gamma secretasa"

Country Status (21)

Country Link
US (2) US7208602B2 (es)
EP (1) EP1472223A1 (es)
JP (1) JP4758609B2 (es)
KR (1) KR20040081489A (es)
CN (1) CN1628100A (es)
AR (1) AR038482A1 (es)
AU (1) AU2003210865B2 (es)
BR (1) BR0307492A (es)
CA (1) CA2478423A1 (es)
CO (1) CO5611195A2 (es)
EC (1) ECSP045218A (es)
MX (1) MXPA04007659A (es)
MY (1) MY141504A (es)
NO (1) NO329067B1 (es)
NZ (1) NZ534223A (es)
PE (1) PE20030977A1 (es)
PL (1) PL371735A1 (es)
RU (1) RU2004126864A (es)
TW (1) TW200302717A (es)
WO (1) WO2003066592A1 (es)
ZA (1) ZA200406237B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399775B2 (en) 2001-12-27 2008-07-15 Daiichi Pharmaceutical Co., Ltd. β-amyloid protein production/secretion inhibitor
US20040171614A1 (en) * 2002-02-06 2004-09-02 Schering-Plough Corporation Novel gamma secretase inhibitors
US7256186B2 (en) 2002-02-06 2007-08-14 Schering Corporation Gamma secretase inhibitors
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2004080966A1 (ja) 2003-03-14 2004-09-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
RU2336270C2 (ru) 2003-06-30 2008-10-20 Дайити Фармасьютикал Ко., Лтд. Гетероциклические метилсульфоновые производные
EP1660443B1 (en) 2003-08-08 2009-03-04 Schering Corporation Cyclic amine bace-1 inhibitors having a benzamide substituent
MXPA06001558A (es) 2003-08-08 2006-05-15 Schering Corp Inhibidores de amina ciclica bace-1 que poseen un sustituyente heterociclico.
CA2544350A1 (en) 2003-10-29 2005-05-12 Elan Pharmaceuticals, Inc. N-substituted benzene sulfonamides
KR20070010144A (ko) * 2004-04-05 2007-01-22 쉐링 코포레이션 신규한 감마 세크레타제 억제제
EP1758884A2 (en) * 2004-05-20 2007-03-07 Elan Pharmaceuticals, Inc. N-cyclic sulfonamido inhibitors of gamma secretase
CN101602741A (zh) * 2004-06-30 2009-12-16 先灵公司 作为γ-分泌酶抑制剂的取代的N-芳基磺酰基杂环胺
AU2005261932B2 (en) * 2004-07-13 2011-10-13 F. Hoffmann-La Roche Ag Sulfonamide derivatives
ATE491693T1 (de) 2004-07-22 2011-01-15 Schering Corp Substituierte amide als inhibitoren der beta- sekretase
NZ553696A (en) 2004-09-13 2010-02-26 Ono Pharmaceutical Co Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
GB0423356D0 (en) * 2004-10-21 2004-11-24 Merck Sharp & Dohme Therapeutic agents
EP1916985A4 (en) * 2005-08-19 2010-06-09 Elan Pharm Inc BRIDGED N-CYCLIC SULPHONAMIDE INHIBITORS OF THE GAMMED CRYSTETRY
WO2007105637A1 (ja) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
EP2041181B1 (en) * 2006-06-08 2011-05-18 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Specific protease inhibitors and their use in cancer therapy
MX2009003382A (es) * 2006-09-29 2009-04-08 Gruenenthal Gmbh Derivados de sulfonamidas sustituidos.
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
CN101534824A (zh) * 2006-11-17 2009-09-16 艾博特公司 作为化学活素受体拮抗剂的氨基吡咯烷
JP5523107B2 (ja) 2006-11-30 2014-06-18 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
US8080549B2 (en) * 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
NZ582039A (en) * 2007-05-25 2012-02-24 Elan Pharm Inc Pyrazolopyrrolidines as inhibitors of gamma secretase
JP2011523655A (ja) * 2008-06-03 2011-08-18 フレセニウス メディカル ケア ドイッチュランド ゲーエムベーハー ガンマセクレターゼモジュレータを含む医薬組成物
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
CN105189482A (zh) 2013-02-07 2015-12-23 武田药品工业株式会社 作为毒蕈碱m4受体激动剂的哌啶-1-基羧酸酯和氮杂卓-1-基羧酸酯
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687146B1 (fr) * 1992-02-12 1994-04-01 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US6166037A (en) * 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
GB9800750D0 (en) * 1998-01-14 1998-03-11 Lilly Co Eli Pharmaceutical compound
GB9804426D0 (en) * 1998-03-02 1998-04-29 Pfizer Ltd Heterocycles
TW575561B (en) * 1999-03-25 2004-02-11 Hoffmann La Roche 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
US6589978B2 (en) * 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives

Also Published As

Publication number Publication date
US20040048848A1 (en) 2004-03-11
MXPA04007659A (es) 2005-06-08
NO20043696L (no) 2004-11-05
US20060100427A1 (en) 2006-05-11
JP2005522437A (ja) 2005-07-28
AU2003210865B2 (en) 2008-01-31
BR0307492A (pt) 2004-11-23
JP4758609B2 (ja) 2011-08-31
PE20030977A1 (es) 2003-12-04
PL371735A1 (en) 2005-06-27
AU2003210865A1 (en) 2003-09-02
US7208602B2 (en) 2007-04-24
KR20040081489A (ko) 2004-09-21
CN1628100A (zh) 2005-06-15
NO329067B1 (no) 2010-08-16
NZ534223A (en) 2007-05-31
EP1472223A1 (en) 2004-11-03
CA2478423A1 (en) 2003-08-14
MY141504A (en) 2010-05-14
TW200302717A (en) 2003-08-16
ZA200406237B (en) 2005-09-22
AR038482A1 (es) 2005-01-19
WO2003066592A1 (en) 2003-08-14
RU2004126864A (ru) 2005-07-10
CO5611195A2 (es) 2006-02-28

Similar Documents

Publication Publication Date Title
BR0307492A (pt) Inibidores de gama secretase
TW200519087A (en) Novel gamma secretase inhibitors
PE20220139A1 (es) Compuestos de tioeno[3,2-b] piridin-7-amina para tratar la disautonomia familiar
MX2008014908A (es) Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo.
BRPI0510365A (pt) composto, método de produção de um composto, antagonista do receptor nk2, pró-droga, agente farmacêutico, métodos para antagonizar um recpetor nk2 e para evitar ou tratar doenças gastrintestinais funcionais, e, uso do composto ou uma pró-droga do mesmo
AR053662A1 (es) Compuestos de pirazol inhibidores de la actividad quinasa cdk y gsk
AR033379A1 (es) Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
MX2009005449A (es) Compuesto heteromonociclico y uso del mismo.
TW200720252A (en) Cyclic amine derivative having substituted alkyl group
PE20091095A1 (es) Moduladores de gamma secretasa
ATE528304T1 (de) Verbindungen und verfahren zur behandlung von dyslipidämie
NO20062988L (no) Sykliske aminderivater med heteroarylring
ATE398125T1 (de) Chinazolin-derivate als tgf-beta-inhibitoren
TW200633991A (en) Chemical compounds
WO2005097129A3 (en) 6-azaindole compound
PE20050482A1 (es) Derivados de dihidrobenzofuranilo alcanamida
AR015512A1 (es) Derivados ciclicos n-acilo amina, un procedimiento para su preparacion, un intermediario y una composicion farmaceutica
ATE439840T1 (de) Kristalline form iii von wasserfreiem moxifloxacin-hydrochlorid und ein verfahren zu seiner herstellung
ECSP056232A (es) Nuevos compuestos
CO6260132A2 (es) Derivados de oxadiazol como inhibidores de dgat
UY28333A1 (es) Inhibidores de caspasa y sus usos.
MX2010008818A (es) Derivado de bicicloamina.
EP1757594A4 (en) quinazoline derivative
NO20082077L (no) Spirosykliske quinazolinderivater som PDE7-inhibitorer